5 Top Emerging Digital Twin Startups Impacting Industry 4.0
Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on solutions for Industry 4.0. As there is a large number of startups working on a wide variety of solutions, we want to share our insights with you. This time, we are taking a look at 5 promising digital twin startups.
Labels
Saturday, 11 July 2020
CBInsights: 5 Top Emerging Digital Twin Startups Impacting Industry 4.0
Monday, 6 July 2020
Indian Startup Stories: With partners like Delhivery and Shadowfax, Delhi-based startup Pickrr is simplifying logistics
With partners like Delhivery and Shadowfax, Delhi-based startup Pickrr is simplifying logistics
The logistics sector earned infrastructure status in 2017 when its market size was estimated at $160 billion. According to IBEF, the Indian logistics market was expected to reach $215 billion by 2020, logging a 10.5 percent CAGR over 2017. However, the sector continues to remain highly fragmented and unorganised.
Saturday, 4 July 2020
Venture Capital: Facebook co-founder's B Capital Group closes its second fund at $820M
Facebook co-founder's B Capital Group closes its second fund at $820M
B Capital Group, a US and Singapore-based investment company have announced the closing of its second $820 million venture fund to invest in growth-stage startups that are disrupting large industries and quickly scaling up. Founded in 2014 by Raj Ganguly, and Facebook co-founder Eduardo Saverin, B Capital Group invests in enterprise technology (including SaaS, AI...
Wednesday, 1 July 2020
Startup Funding Alert: French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu
French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu
Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank's Large Venture fund. This Series A extension brings the startup's total amount raised to $70 million. The AI platform connects data scientists, clinicians, academic researchers and pharmaceutical companies to create global ...
Tuesday, 23 June 2020
Google Creates a New Source of Traffic With Keen - Search Engine Journal
Google Creates a New Source of Traffic With Keen - Search Engine Journal
Google has quietly announced a content discovery service called Keen. Keen is being referred to as a Pinterest competitor but that's not entirely accurate. Keen is a machine learning app that actively promotes relevant web pages to users. Keen is poised to become a new source of referral traffic, which makes it worthy of investigation.
Monday, 22 June 2020
Help a Startup: New Microsoft programme Azure Farmbeats to empower agritech startups in India
New Microsoft programme to empower agritech startups in India | The Rahnuma Daily
New Delhi, June 3 (IANS) Microsoft on Wednesday launched a new programme to help agritech startups in India build industry-specific solutions, scale and grow with access to deep technology, business and marketing resources. The three-tier programme offers tech and business enablement resources to Series C startups that can boost their businesses with Azure benefits (including free ...
Sunday, 21 June 2020
Growing a global SaaS business - the LogiNext way
Growing a global SaaS business - the LogiNext way
Serving 150+ enterprises, LogiNext has quickly become a household name in the global retail and transportation industry. Apart from building the platform as an experience differentiator, LogiNext's growth has been catapulted by its ability to leverage niche and domain specific channel partnerships
Startup Ideas - Blockchain based distributed super-computing technologies
OCD drug designed by artificial intelligence
'Cutting-edge science': OCD drug designed by artificial intelligence
Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder designed by artificial intelligence. British startup Exscientia and Japan's Sumitomo Dainippon Pharma used artificial intelligence to create the drug in less than 12 months, cutting four years from the average time it takes ordinary humans to develop a medication.